Assessment of the diagnostic performance of the 1 mg dexamethasone suppression test in class 3 obese patients

Publicado en línea: 20 oct 2022

Páginas: 265 - 270

DOI: https://doi.org/10.2478/enr-2022-0028

Palabras clave

obesity, Cushing’s syndrome, screening, dexamethasone suppression test

© 2022 Suleyman Baldane et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.